Apyx Medical Corp Revenue from Contract with Customer, Including Assessed Tax
Apyx Medical Corp (APYX) reported Revenue from Contract with Customer, Including Assessed Tax of $13.88 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-06
- Apyx Medical Corp revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $13.88M, a 22.08% increase year-over-year.
- Apyx Medical Corp revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $12.49M, a 32.45% increase year-over-year.
- Apyx Medical Corp revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $19.16M, a 34.75% increase year-over-year.
- Apyx Medical Corp revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $12.88M, a 12.10% increase year-over-year.
- Apyx Medical Corp revenue from contract with customer, including assessed tax for fiscal 2025 was $52.84M, a 9.86% increase from fiscal 2024.
- Apyx Medical Corp revenue from contract with customer, including assessed tax for fiscal 2024 was $48.10M, a 8.11% decline from fiscal 2023.
- Apyx Medical Corp revenue from contract with customer, including assessed tax for fiscal 2023 was $52.35M.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.88M 10-Q · filed 2026-08-06 | $26.37M 10-Q · filed 2026-08-06 | $45.54M derived: sum of 3 quarters · filed 2026-08-06 | $58.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $12.49M 10-Q · filed 2026-05-07 | $31.65M derived: sum of 2 quarters · filed 2026-05-07 | $44.53M derived: sum of 3 quarters · filed 2026-05-07 | $55.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $19.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $32.04M derived: sum of 2 quarters · filed 2026-03-10 | $43.41M derived: sum of 3 quarters · filed 2026-08-06 | $52.84M 10-K · filed 2026-03-10 |
| 2025-09-30 | $12.88M 10-Q · filed 2025-11-06 | $24.25M derived: sum of 2 quarters · filed 2026-08-06 | $33.68M 10-Q · filed 2025-11-06 | $47.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $11.37M 10-Q · filed 2026-08-06 | $20.80M 10-Q · filed 2026-08-06 | $35.02M derived: sum of 3 quarters · filed 2026-08-06 | $46.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $9.43M 10-Q · filed 2026-05-07 | $23.65M derived: sum of 2 quarters · filed 2026-05-07 | $35.14M derived: sum of 3 quarters · filed 2026-05-07 | $47.29M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $14.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $25.71M derived: sum of 2 quarters · filed 2026-03-10 | $37.86M derived: sum of 3 quarters · filed 2026-03-10 | $48.10M 10-K · filed 2026-03-10 |
| 2024-09-30 | $11.49M 10-Q · filed 2025-11-06 | $23.64M derived: sum of 2 quarters · filed 2025-11-06 | $33.88M 10-Q · filed 2025-11-06 | $48.54M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $12.15M 10-Q · filed 2025-08-07 | $22.39M 10-Q · filed 2025-08-07 | $37.05M derived: sum of 3 quarters · filed 2025-08-07 | $49.03M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $10.24M 10-Q · filed 2025-05-08 | $24.91M derived: sum of 2 quarters · filed 2025-05-08 | $36.88M derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | $14.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $26.64M derived: sum of 2 quarters · filed 2025-03-13 | $52.35M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $11.98M 10-Q · filed 2024-11-08 | $37.69M 10-Q · filed 2024-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |